{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:08:04Z","timestamp":1791194884953,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"DOI":"10.1097\/qad.0b013e3283536a6c","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T15:48:16Z","timestamp":1332431296000},"page":"1095-1103","source":"Crossref","is-referenced-by-count":63,"title":["When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?"],"prefix":"10.1097","volume":"26","author":[{"given":"Phillip J.","family":"Read","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundhiya","family":"Mandalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palwasha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Harrisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Naftalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Gilleece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"de Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission.","volume":"341","author":"Garcia","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00042560-199806010-00004","article-title":"Maternal cell-free viremia in the natural history of perinatal HIV-1 transmission: a meta-analysis.","volume":"18","author":"Contopoulos-Ioannidis","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(98)08084-2","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1468-1293.2009.00800.x","article-title":"Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.","volume":"11","author":"Boer","year":"2010","journal-title":"HIV Med"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.","volume":"40","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e3282f9b67a","article-title":"Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.","volume":"22","author":"Townsend","year":"2008","journal-title":"AIDS"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1464-2662.2001.00082.x","article-title":"Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission.","volume":"2","author":"Lyall","year":"2001","journal-title":"HIV Med"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/2047-783X-14-11-461","article-title":"German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.","volume":"14","author":"Buchholz","year":"2009","journal-title":"Eur J Med Res"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1468-1293.2008.00619.x","article-title":"British HIV Association and Childrens HIV Association guidelines for the management of HIV infection in pregnant women 2008.","volume":"9","author":"de Ruiter","year":"2008","journal-title":"HIV Med"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1086\/650005","article-title":"Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load 500copiesml at delivery: A case-control study nested in the French Perinatal Cohort (EPF-ANRS CO1).","volume":"50","author":"Tubiana","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0140-6736(09)60918-1","article-title":"Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.","volume":"374","author":"Lennox","year":"2009","journal-title":"Lancet"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1086\/518284","article-title":"Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QAI.0b013e3181caea89","article-title":"Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.","volume":"54","author":"Katz","year":"2010","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006842-200307000-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T17:18:07Z","timestamp":1713719887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201206010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,1]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283536a6c","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716647803.792002950","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,1]]}}}